Abstract

We investigated the possible involvement of the autonomic nervous system in the effect of a long-term elevation of plasma free fatty acid (FFA) concentration on glucose-induced insulin secretion (GIIS) in rats. Rats were infused with an emulsion of triglycerides (Intralipid) for 48 hours (IL rats). This resulted in a twofold increase in plasma FFA concentration. At the end of infusion, GIIS as reflected in the insulinogenic index (DeltaI/DeltaG) was 2.5-fold greater in IL rats compared with control saline-infused rats. The ratio of sympathetic to parasympathetic nervous activities was sharply decreased in IL rats relative to controls. GIIS was studied in the presence of increasing amounts of alpha- and beta-adrenoreceptor agonists and antagonists. The lowest concentrations of the alpha2A-adrenoreceptor agonist oxymetazoline, which were ineffective in control rats, reduced GIIS in IL rats. At the dose of 0.3 pmol/kg, GIIS became similar in IL and control rats. The use of beta-adrenoreceptor agonist (isoproterenol) or antagonist (propranolol) did not result in a significant alteration in GIIS in both groups. GIIS remained as high in IL vagotomized rats as in intact IL rats, indicating that changes in parasympathetic tone were of minor importance. Altogether, the data show that lipid infusion provokes beta-cell hyperresponsiveness in vivo, at least in part through changes in alpha2-adrenergic innervation.

Keywords

EndocrinologyInternal medicineAgonistPropranololSympathetic nervous systemChemistryOxymetazolineAutonomic nervous systemInsulinReceptorMedicineHeart rate

Affiliated Institutions

Related Publications

Publication Info

Year
1999
Type
article
Volume
103
Issue
3
Pages
413-419
Citations
111
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

111
OpenAlex

Cite This

Chr̀istophe Magnan, Stephan C. Collins, Marie‐France Berthault et al. (1999). Lipid infusion lowers sympathetic nervous activity and leads to increased β-cell responsiveness to glucose. Journal of Clinical Investigation , 103 (3) , 413-419. https://doi.org/10.1172/jci3883

Identifiers

DOI
10.1172/jci3883